Transcriptional adaptation opens new therapeutic possibilities for Duchenne muscular dystrophy and rare neuromuscular diseases
Rare Disease and Orphan Drugs Journal · 14.08.2026 · 5 (3)
DOI: 10.20517/rdodj.2026.35 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, online erschienen am 14.08.2026. Verfasst von Anika Nusrat und 1 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nusrat, A., & Wehrens, X. H. T. (2026). Transcriptional adaptation opens new therapeutic possibilities for Duchenne muscular dystrophy and rare neuromuscular diseases. Rare Disease and Orphan Drugs Journal, 5(3). https://doi.org/10.20517/rdodj.2026.35
Vancouver
Nusrat A, Wehrens XHT. Transcriptional adaptation opens new therapeutic possibilities for Duchenne muscular dystrophy and rare neuromuscular diseases. Rare Disease and Orphan Drugs Journal. 2026;5(3). doi:10.20517/rdodj.2026.35
BibTeX
@article{Nusrat2026,
author = {Nusrat, Anika and Wehrens, Xander H. T.},
title = {Transcriptional adaptation opens new therapeutic possibilities for Duchenne muscular dystrophy and rare neuromuscular diseases},
journal = {Rare Disease and Orphan Drugs Journal},
year = {2026},
volume = {5},
number = {3},
doi = {10.20517/rdodj.2026.35}
}
EUVIMED